LXEO

NASDAQStock

Lexeo Therapeutics, Inc. Common Stock

$6.54-0.09 (-1.36%)

52-Week Range

$1.79
$10.63

Key Stats

Market Cap

477.3M

P/E Ratio

Dividend Yield

Beta

1.80

Volume

1.1M

Avg Volume

816.9K

Performance

1M

+0.91%

3M

-32.07%

6M

+23.23%

YTD

-31.01%

1Y

+115.96%

3Y

-34.03%

5Y

-34.03%

Price Chart

ETF Exposure

LXEO is held by 70 ETFs

ETFFund NameWeight
DFAUDimensional - US Core Equity Market ETF0.00%
ITDBiShares LifePath Target Date 2030 ETF0.00%
ITDCiShares LifePath Target Date 2035 ETF0.00%
ITDDiShares LifePath Target Date 2040 ETF0.00%
ITDEiShares LifePath Target Date 2045 ETF0.00%
ITDFiShares LifePath Target Date 2050 ETF0.00%
ITDGiShares LifePath Target Date 2055 ETF0.00%
ITDHiShares LifePath Target Date 2060 ETF0.00%
ITDIiShares LifePath Target Date 2065 ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.00%
LSLTPacer Salt Low truBeta US Market ETF0.00%
SLTPacer Salt High truBeta US Market ETF0.00%
TRPLPacer Metaurus US Large Cap Dividend Multiplier 300 ETF0.00%
VCNS.TOVanguard Conservative ETF Portfolio0.00%
VEQT.TOVanguard All-Equity ETF Portfolio0.00%
VETSPacer Military Times Best Employers ETF0.00%
VIRSPacer BioThreat Strategy ETF0.00%
VRIF.TOVanguard Retirement Income ETF Portfolio0.00%
XEQT.TOiShares Core Equity ETF Portfolio0.00%
XUU.TOiShares Core S&P U.S. Total Market Index ETF0.00%
PreviousPage 2 of 2

About LXEO ETF Exposure

Lexeo Therapeutics, Inc. Common Stock (LXEO) is held by 70 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 477.3M, LXEO is a widely held institutional stock. The stock currently trades at $6.54. Investors can gain exposure to LXEO through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold LXEO, sorted by portfolio weight.